Friday, September 11, 2009 7:48:50 AM
I agree with all you have said except your argument 4.( Argument 4 :
The share allowance doesn't change so the stock could potentially be diluted 15x more (in other word we could see 95pct dilution).
If OXBO would have made the share allowance a separate vote from the reverse split I would have no problem voting yes to the split. I am not at all comfortable with the share allowance not also reversing. New shares can be voted on and issued as needed correct? Yes or No. If yes then understand my caution.
Lynn, thank you for your time & response. There were a few investor emails sent to us from Abe after he took over our PR dept that were sent in groups alphabetically When the issue of his day before a official press release oops email occurred,the group emails from his firm stopped as I recall.
The share allowance doesn't change so the stock could potentially be diluted 15x more (in other word we could see 95pct dilution).
If OXBO would have made the share allowance a separate vote from the reverse split I would have no problem voting yes to the split. I am not at all comfortable with the share allowance not also reversing. New shares can be voted on and issued as needed correct? Yes or No. If yes then understand my caution.
Lynn, thank you for your time & response. There were a few investor emails sent to us from Abe after he took over our PR dept that were sent in groups alphabetically When the issue of his day before a official press release oops email occurred,the group emails from his firm stopped as I recall.
Recent TENX News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/20/2026 09:05:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:55:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:26:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 09:08:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:56:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/12/2026 09:01:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:07 PM
- Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 10:19:02 PM
- Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
